And Pfizer and Novartis are leading the pack. The risks involved with drugmakers building their own manufacturing plants are big but so are the potential rewards. In other pharmaceutical news: a …
Drugmakers Betting Big On Gene Therapy By Investing Combined $2B Into Manufacturing Pricey Treatments
Drugmakers Betting Big On Gene Therapy By Investing Combined $2B Into Manufacturing Pricey Treatments
Leave a reply